<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00249548</url>
  </required_header>
  <id_info>
    <org_study_id>NIDA-13444-3</org_study_id>
    <secondary_id>R01-13444-3</secondary_id>
    <nct_id>NCT00249548</nct_id>
  </id_info>
  <brief_title>Low-Cost Contingency Management for Hispanic Outpatients - 3</brief_title>
  <official_title>Low-Cost Contingency Management for Hispanic Outpatients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>UConn Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute on Drug Abuse (NIDA)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of a lower-cost contingency&#xD;
      management (CM) procedure in Hispanic substance abusing outpatients. Thirty individuals&#xD;
      meeting DSM-IV criteria for substance dependence receive one of two conditions: (a) standard&#xD;
      treatment, or (b) standard treatment plus prize CM. Using a cross-over design, CM is&#xD;
      implemented in a community-based outpatient clinic and compared with non-CM in the same&#xD;
      clinic. The participating clinic is randomly assigned to receive either the CM or non-CM&#xD;
      phase first; 15 weeks after the final participant in one phase is enrolled, a one-week&#xD;
      washout period occurs, followed by a switch to the other phase. Patients initiating&#xD;
      outpatient treatment during the non-CM phase receive standard treatment and submit urine and&#xD;
      breath samples 2/week during Weeks 1-6 and 1/week during Weeks 7-12. Patients initiating&#xD;
      treatment during the CM phase also receive standard treatment and the same breath and urine&#xD;
      monitoring. In addition, they earn the opportunity to win prizes for coming to treatment and&#xD;
      for submitting negative breath and urine samples. Follow-up interviews are conducted at 1,3,6&#xD;
      and 9 months following intake during which substance use and psychosocial functioning are&#xD;
      assessed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2004</start_date>
  <completion_date type="Actual">January 2006</completion_date>
  <primary_completion_date type="Actual">January 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Drug use</measure>
    <time_frame>baseline and each follow-up</time_frame>
  </primary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Substance Abuse</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Contingency management</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  age &gt; 18 years&#xD;
&#xD;
          -  current DSM-IV substance dependence.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  have a serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar&#xD;
             disorder, severe or psychotic major depression, or suicide risk) on the basis of&#xD;
             history or medical examination&#xD;
&#xD;
          -  have dementia (&lt;23 on the Mini Mental State Exam; Folstein et al. 1975)&#xD;
&#xD;
          -  DSM-IV diagnosis of pathological gambling&#xD;
&#xD;
          -  plans to move from the Hartford are within 9 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nancy Petry, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>UConn Health</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>May 2008</verification_date>
  <study_first_submitted>November 3, 2005</study_first_submitted>
  <study_first_submitted_qc>November 3, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2005</study_first_posted>
  <last_update_submitted>January 11, 2017</last_update_submitted>
  <last_update_submitted_qc>January 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2017</last_update_posted>
  <responsible_party>
    <name_title>Nancy Petry, Ph.D.</name_title>
    <organization>UConn Health Center</organization>
  </responsible_party>
  <keyword>contingency management</keyword>
  <keyword>substance abuse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

